The sealed top provides easy needle insertion while keeping the liquids safely contained for mixing
Related Reading Compounded Semaglutide 2 Compounded Semaglutide What Genetic Factors Affect Ptsd Severity How Can Understanding Help Manage Risks How Do Genetic Factors Affect Mood And Depression And How Can Understanding Help Mental Health Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Sources Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021) The New England Journal of Medicine [accessed 10th February 2026] Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial (2022) Nature Medicine ] [accessed 10th February 2026] Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity (STEP 4) (2021) JAMA ] [accessed 10th February 2026] Semaglutide 2.4 mg once weekly in adults with overweight or obesity, and type 2 diabetes (STEP 2 Trial) (2021) The Lancet ] [accessed 10th February 2026] Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg solution for injection in pre-filled pen (2024) Electronic Medicines Compendium (EMC): Patient Information Leaflet ] [accessed 10th February 2026] Wegovy (semaglutide) Summary of Product Characteristics (2024) Electronic Medicines Compendium (EMC) ] [accessed 10th February 2026] MHRA approves GLP-1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults (2024) GOV.UK ] [accessed 10th February 2026] Semaglutide and Cardiovascular Outcomes in Patients With Overweight or Obesity (SELECT Trial) (2023) PubMed / SELECT CVOT Overview [accessed 10th February 2026] A Research Study to Look at How Well Semaglutide Helps People Lose Weight (STEP UP Phase 3b) (2024) ClinicalTrials.gov ] [accessed 10th February 2026] Wegovy (semaglutide) Injection: Your Complete Guide to Wegovy Pen (2026) Novo Nordisk ] [accessed 10th February 2026] Semaglutide for managing overweight and obesity (2023) NICE ] [accessed 10th February 2026] Medically reviewed by reviewed by Tannaz Sohrabi (MPharm, PGDip, IP, MRPharmS) GPhC Number: 2225756 Last reviewed: 17th April 2026 Meet our medical professionals medical professionals Sunny Dhain Clinical Director Kamaldeep Kaur Pharmacist Prescriber Aaliyah Nelson Nutritional Coaching BSc (Hons) Nutrition: 47988 Standards first always always
The drug helps control cravings, which can be a significant factor in weight management
This happens because the medication's appetite-suppressing effects fade quickly once treatment ends
Tirzepatide effetti collaterali: quali sono
